Follow-The-Filings

Security · featured owners

CRBP Corbus Pharmaceuticals Hldgs

Health Care COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.2%
  • $1M
  • 1 new

CRBP (Corbus Pharmaceuticals Hldgs) is held in 1 featured 13F book as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (0.19%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.2% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel new 0.19%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.19% New 0.19% 107,773 $1M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$44.6M -$40.21M -$78.54M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $23.55M $152.98M $166.95M
Total non-current assets * $4.73M $2.9M $1.24M
Total assets $28.27M $155.88M $168.2M
Total current liabilities $31.89M $11.82M $20.69M
Total non-current liabilities * $3.28M $1.63M $0M
Total equity -$6.9M $142.43M $147.5M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$36.1M -$41.79M -$64.49M
Cash from investing $35.64M -$121.31M -$1.64M
Cash from financing -$2.82M $166.58M $77.43M
Net change in cash -$3.28M $3.47M $11.29M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders